PubRank

Norman Fost

Author PubWeight™ 29.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ashley revisited: a response to the critics. Am J Bioeth 2010 7.15
2 The dysregulation of human subjects research. JAMA 2007 3.44
3 Community consultation and communication for a population-based DNA biobank: the Marshfield clinic personalized medicine research project. Am J Med Genet A 2008 2.74
4 The cystic fibrosis gene: medical and social implications for heterozygote detection. JAMA 1990 2.02
5 Health Insurance Portability Accountability Act (HIPAA) regulations: effect on medical record research. Ann Surg 2004 1.55
6 An Institutional Review Board dilemma: responsible for safety monitoring but not in control. Clin Trials 2006 1.11
7 Genetic data and electronic health records: a discussion of ethical, logistical and technological considerations. J Am Med Inform Assoc 2013 1.03
8 hGH for short stature: ethical issues raised by expanded access. J Pediatr 2004 1.00
9 Ethical issues in clinical research on fracture prevention in patients with osteoporosis. J Bone Miner Res 2003 0.90
10 Deferring consent with incompetent patients in an intensive care unit. IRB 1981 0.87
11 A pilot seminar on ethical issues in clinical trials for cancer researchers in Vietnam. IRB 2004 0.83
12 Childhood obesity and medical neglect. Pediatrics 2009 0.81
13 Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions. J Pediatr 2005 0.81
14 Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention. J Interv Cardiol 2003 0.80
15 Passive euthanasia of defective newborn infants: legal considerations. J Pediatr Surg 1976 0.79
16 Prenatal screening for cystic fibrosis: where are we now? J Pediatr 2002 0.79
17 Growth-attenuation therapy: principles for practice. Pediatrics 2009 0.78
18 Perceived risks of participation in an epidemiologic study. IRB 1993 0.77
19 The ambiguities of 'deferred consent' IRB 1981 0.76
20 "Doping" is pejorative and misleading. BMJ 2008 0.75
21 Hemoglobin-based blood substitutes and risk of myocardial infarction and death. JAMA 2008 0.75
22 Ashley revisited: a response to the peer commentaries. Am J Bioeth 2010 0.75
23 Obesity and neglect: it's about the child. J Pediatr 2012 0.75
24 Food for thought: Dresser on anorexia. Wis L Rev 1984 0.75
25 Drug testing in adolescents. Virtual Mentor 2005 0.75
26 "I was like -- whoa": a commentary on Shapiro's Performance enhancement and the control of attributes. South Calif Law Rev 1991 0.75
27 Treatment of seriously ill and handicapped newborns. Crit Care Clin 1986 0.75